chrisvoncsefalvay/vaers-outcomes huggingface dataset:
decreased thyroid function; increased atrial fibrillation; Hair loss; bruising; slight confusion; memory loss; exhaustion; significantly increased depression; sensitivity to cold; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received the second dose of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine), via an unspecified route of administration, administered in the right arm on 24Mar2021 (Batch/Lot Number: EP6955) at the age of 74-years-old, single, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not pregnant, did not have any other vaccines within four weeks, did not have COVID prior to vaccination, and was not COVID tested post vaccination. The patient previously received the first dose of BNT162B2 on 24Feb2021 (Lot number: EN6202) in the left arm for COVID-19 immunization; and levothyroxine. The patient stated that she had taken the same level of levothyroxine for many years, and suddenly she started having breakthrough symptoms (after the Pfizer vaccinations) in Mar2021: hair loss, bruising, increased atrial fibrillation, slight confusion and memory loss, exhaustion, significantly increased depression, and sensitivity to cold. According to laboratory results on 14Sep2021, the patient had significantly decreased thyroid function. Outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
Developed erythematous macule papular rash over arms, abdomen and face. Also has swelling of wrist.
About 2 days after receiving the vaccine, she bitter taste in her mouth. She still has it as of today. It is kind of metallic taste. She also has blurry vision and swelling in her eyes. It felt like she had discomfort behind her eyes. It was causing difficultly reading. This lasted about 2 weeks.  It is not as blurry but her vision is not what it is was prior to receiving the vaccine. She went to Eye Center, they told her they didn't know what it was from. They gave her some eye drops and gave her antibiotic/steroid  cream. She has a follow up appointment 2/26/2021.
Patient received first Moderna vaccine on  04/26/21 Lot#014C21A, received second dose Moderna on 5/07/21  lot#022C21A. Patient denies any symptoms at this times.
Ma informed RN that she had administered by accident double dose of Rota virus vaccine. Pt mom was called and informed of situation. Mom was informed that the provider was aware as well as Nurse manager. Mom was given ER warnings as stated by Dr. Mom was advised to call the clinic if she had any questions or concerns. Mom stated that pt is stable and alert at the moment.
devel red papules over the leg where recv vax & around the lips all w/in 48hrs of vax;
Swollen lymph nodes in. Left armpit 3 days after second dose of Pfizer covid vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old female patient received bnt162b2 (BNT162B2) (Lot number: EN6207) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose :1), for COVID-19 immunisation.  The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "Swollen lymph nodes in. Left armpit 3 days after second dose of Pfizer covid vaccine".  No follow-up attempts are possible. No further information is expected.
Diarrhea for three months after the shot, and still experiencing it periodically. Flare ups with sciatica and leg pain.
Information has been received on 15-FEB-2019 regarding a case in litigation from a lawyer concerning female patient of unknown age. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In March 2017, the patient was administered the ZOSTAVAX (lot number, expiration, dose and route unknown) by a physician at a community health center. On an unknown date, the patient was treated by a physician at a hospital for the following injuries resulting from the patient's ZOSTAVAX use: shingles. The patient claims damages as a result of injury to self and economic losses. The outcome of the event is unknown. The causality of the event is related. Additional information has been requested.
Exactly 2.5 hours after vaccination,  at 8:30 pm, I experienced sudden onset of intense, loud, disorienting, whooshing pulsatile tinnitus in right ear. A few minutes later, I felt flushed and had momentary dizziness and nausea. That passed, but the pulsatile tinnitus grew worse. I am a family medicine physician who practices acupuncture, so I lay on the couch and needled myself at GB-2, TH-17, TH-3, GB-43 and in 30 minutes, at 9:30 pm, the tinnitus had completely resolved. I went to bed and fell asleep a little around 10:30 pm, but awoke at 11 pm due to the return of loud pulsatile whooshing in right ear. This continued unabated until I put on music to distract the sound and fell asleep again around 12:30 am. I awoke at 5:20 am with mild whooshing, went to work at clinic and as of 3 pm, the tinnitus has not returned (thank goodness!)
per patient: "Hi I don?t know if your keeping track of any adverse immune reactions to the booster. I wanted to let the pharmacy know that I  develop a painful rash on my arm at the injection  sport.  I guess it?s called ?covid arm?. The rash is very painful and uncomfortable. My arm feels like it?s on fire.  I also had fever for three days.  The rash seems to be growing. I read that this covid arm goes away after a week. I am treating it with OTC pain relief cream and antihistamine.  If my rash is not better by Monday I will go see my doctor. "
Plaque psoriasis flare up on scalp flakey/faint; Sore arm; fatigued with skyrizi; Achiness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achiness), PSORIASIS (Plaque psoriasis flare up on scalp flakey/faint ), PAIN IN EXTREMITY (Sore arm) and FATIGUE (fatigued with skyrizi) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) 1 dosage form. On 03-Mar-2021, the patient experienced PAIN (Achiness), PAIN IN EXTREMITY (Sore arm) and FATIGUE (fatigued with skyrizi). On an unknown date, the patient experienced PSORIASIS (Plaque psoriasis flare up on scalp flakey/faint ). At the time of the report, PAIN (Achiness), PAIN IN EXTREMITY (Sore arm) and FATIGUE (fatigued with skyrizi) outcome was unknown and PSORIASIS (Plaque psoriasis flare up on scalp flakey/faint ) had not resolved.            This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  The concomitant medication was not reported.  The reporter causality for the events Pain in arm, Ache, Fatigue with respect to skyrizi (risankizumab) was reported as no reasonable possibility. And the causality for the event of Psoriasis flares-up with respect to skyrizi (risankizumab) was reported as reasonable possibility.  The treatment medication was not provided.
I started developing a rash, and itching a lot. I had blotches of rash on my skin, but not the one showing online from the shot. It is still present on my skin. It looks like little, round blotches in weird color. They're very smooth and look like bruises, but are not. they're round but in different sizes in spots on my body and itch a lot. The rash will also blister and become open sores   The rashes fade, but then come back.
Severe pain in all joints normally affected by her arthritis; This is a spontaneous report received from a non-contactable healthcare professional reporting for herself via a Pfizer sales representative. A female patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13), via an unspecified route of administration, on an unspecified date, at single dose, for immunisation.  Medical history included ongoing rheumatoid arthritis. Concomitant medications were not reported. The patient experienced severe pain in all joints normally affected by her arthritis for 30 hours afterward. The event recovered spontaneously. She had the same experience 8 weeks later after Pneumovax 23 vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient might have received an improperly stored dose of one of the following vaccine: PEDVAXHIB (lot # N000236; expiry date: 24-OCT-2019) (or) GARDASIL 9 (lot # M040412; expiry date: 30-JUN-2019) for prophylaxis (dosing details not reported). The vaccine was exposed to a temperature of 30.9 degree Fahrenheit (F) for 24 hours. No adverse effect was reported. This report was due to digital data logger. There was no previous temperature excursion. Product quality complaint was not involved.
Information has been received from a nurse referring to a 2 month old male patient. Patient's concurrent conditions, concomitant medication and medical history were not provided. On 02-MAR-2015 the patient was inadvertently vaccinated with a dose of PNEUMOVAX 23 (injection, lot#, strength, dose, route and expiry date were not provided) (inappropriate schedule of drug administration). No adverse effect was reported. Additional information has been requested.
Fever, chills, body aches, headache, vomiting, Fluids and rest Symptoms subsided in 48 hours
pregnancy loss / miscarriage  I had the booster on Friday and on Saturday I started to have fever and muscle pain and bleeding heavily (pregnancy age: 4 weeks 5 days)
D Dimer was high; Chest tightness; blood clots in the lungs; This is a spontaneous report from a contactable consumer. A 63-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 14Apr2021 10:30 (Lot Number: ER2613) as SINGLE DOSE for covid-19 immunization. Medical history included ongoing retinal tear from an unknown date (long ago, maybe 2005), Blood pressure, anxiety, reflux, irritable bowel syndrome, eye care. Three years ago, patient had a blood clot on the portal vein. She was treated with Eliquis, referring to Apixaban, for six months. Then they went into the D Dimer and found out she only had one gene for the blood clots, so they discontinued Eliquis, referring to Apixaban. The doctor said the protocol didn't call for it because she only had one gene. Eliquis, referring to Apixaban, was discontinued a year and half ago. The reporter mentioned the specifically didn't get the Johnson and Johnson shot due to blood clots. Family History included that her mother and sister had blood clots in the past unrelated to the vaccine, anxiety which her mom has. Concomitant medications included ramipril taken for blood pressure from an unspecified start date (for five to ten years) and ongoing; ongoing omeprazole taken for reflux; fluoxetine  taken for anxiety (for what her mom has) taking for three years and ongoing; linaclotide (LINZESS) taken for irritable bowel syndrome taking for 3 year and ongoing; magnesium sulfate taken for eye care taking for 3 year and ongoing; latanoprost taken for retinal tear from 2005 and ongoing.  Prior Vaccinations (within 4 weeks) was none. The patient previously received the first dose of the Pfizer COVID 19 vaccine on 26MAR2021 at 1000AM in the right upper arm (Lot number for first dose is ER8732; expiration date 31Jul2021). Last Wednesday she started to have tightness in her chest so they called an ambulance. She was admitted to the hospital 28Apr2021 and was discharged Saturday 01May2021. In the hospital they did a CT and it came out that she had bilateral blood clots in the lungs; the doctor said it was a shower of blood clots in the lungs, small enough not to occlude anything. They treated with a 72 hour heparin drip. They didn't do any more CT but they did put her on Eliquis, referring to Apixaban, for the rest of her life. For the Eliquis he mentioned the generic Apixaban; unknown manufacturer; caller did not see NDC, lot, or expiration date on product dispensed in a pharmacy vial. Last time she was also on the Apixaban, not the brand Eliquis but they have discarded all the old product. The patient also did an X Ray; EKG (Electrocardiogram) was normal sinus; all the blood work including the CBC (Full blood count) was normal on an unknown date; her D Dimer was high on 01May2021. The events required a visit to Emergency Room. The outcome of the event chest pain was recovered with sequelae, of  blood clots in the lungs was not recovered, of other events was unknown.   Batch/Lot number had been obtained. Further information has been requested
11APR94 935AM recvd vax & 430 t102 inst given APAP, sponge bath & lightly dress, push fluids; IN er 6PM  due to inc temp & sz; 12APR94 office f/u inc temp & sz in AM CBC done inc WBC; 13APR94 temp resolved pt activity inc;
This is a spontaneous report received from a pharmacist who reported on an unknown patient (gender unknown) who received a dose of ZOSTAVAX on an unspecified date. The pharmacist reported that the patient developed 'gout' on an unspecified date about 'two weeks' following the administration of ZOSTAVAX. The patient sought unspecified medical attention. There was no treatment provided for the adverse event. The outcome was unknown. Additional information has been requested.
Did not have any adverse symptoms following vaccine other than expected injection site soreness which lasted only 24 hrs. Approx 6 days post vaccine injection, developed itching , mild redness R upper arm surrounding original injection site. Skin continues to be reddened and itchy.  Will obtain and use hydrocortisone cream topically.
tumor on the side of his neck; Developed a tumor on the side of his neck where the jaw bone is.; Neck is so stiff; Ear ache; This is spontaneous report received from a non-contactable consumer(patient). A 91-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on 12Mar2021 as single dose for covid-19 immunization. The patient's medical history was not reported. Concomitant medications included ibuprofen, phenylephrine hydrochloride, acetylsalicylic acid (ASPIRIN (E.C.)) taken for an unspecified indication, start and stop date were not reported. The patient developed a tumor on the side of his neck where the jawbone is, neck is so stiff, ear ache all on an unspecified date. The case was reported as non-serious. The patient received the second dose of Pfizer's COVID vaccine on 12Mar2021 and developed a tumor on the side of his neck where the jawbone was. He was asking what he can take to make it softer and go down. It's been 4 weeks and it has not subsided. He took an ibuprofen and it got really hard that night. The neck is so stiff. The next day, He took a couple acetylsalicylic acid (ASPIRINS) and it got softer. It gave him a little ear ache. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Within minutes vaso vagal syncope.  May not be related.  Has occurred before with other injections or drawing blood.  Next day, injection site soreness.  Fatigue.  Everything normal by day 2
I had a fever the night of the vaccine. The next morning I still had a fever and also got a headache. I took some 800mg of ibuprofen. Which broke the fever for a few hours but it returned in about 5 hours. I took 2 Tylenol then. Again the fever and headache subsided. They returned around midnight or 1am that night. I didn?t take anymore medicine. It broke by itself by 7am the next morning. That day I had a cough for most of the day. All symptoms were gone by the 4th day.
Patient observed for 15 min post HPV vaccination. Pt was noted by nursing staff having an episode of emesis. Pt also noted by this Nurse as pale, cold, sweaty and clammy. Per Parent, Pt responds in this way with any medical procedure. Initial baseline BP pre-vaccination was 110/76. Patient tolerated immunization administration well. BP taken after emesis episode was 84/56. Patient was continually monitored and fanned down by this Nurse and Parent. Pt had another episode of emesis and was given sips of water. Final BP taken again was 92/60 and Pt found A/O x 3 by this Nurse. Pt regained color and no longer cold and clammy. Pt stated he felt much better. Pt released to Parent and instructed to seek medical attention if Parent feels Pt needs further assistance. Parent voiced understanding.
Patient received vaccines on 7/21. Patient expired during the night of 7/22-23. Do not know if expired before or after midnight of 7/22.
One week after the shot I developed a small red itchy bump.  It went away after 2 days.  Then a week after that I developed a rash about 2 inches below the place where I received the shot.  No bump, no itch, just a rash which is where I am right now.
Pregnancy History- Seventh Pregnancy - Third Birth; Birth Weight - 8LBS 2OZ.  I had retained products of the placenta from my pregnancy, and I had to have a DNC because of bleeding. On 02/27/2023, I had a DNC. The following Monday, I developed superficial blood clots in one of my veins in the lower left part of my leg. Around a week later, I developed more and then a few days after that, more developed. After that third incident, I went to see a doctor. The doctor advised Ibuprofen for pain and referred me to a vein specialist. I have not yet been able to see the vein specialist.
Pateint family called at 850pm due to patient complaining of angina on 3/27/19, that started at approx 8pm. Patient had received new routine vaccines at 130pm same day. Patient had history of anigna and stent placements. Instructed to use nitroglycerin tablets SL as directed (1 SL q5min up 3x) and to call 911 if not releived after 3 doses. Followed up with family 3/28/19 and they informed me patient was admitted to hospital that evening and they were waiting for Doctor to make rounds on the patient. No additional information provided or available at that time.
Extreme itching, rash, hives over torso, back, legs, arms and neck, made worse by scratching. Scratching results in raised markings (referred to as dermotographia by diagnosing doctor).  Itching lasts about an hour., marks last longer.  Symptoms started about 12 days after vaccination, and today, 32 days after vaccination, they are still present.  They appear daily at different times and with varying degrees of severity.  The itching sensation has been minimized by the use of Claritin and Benadryl, but the rashes continue to come and go.
Son was extremely fussy and ended up having extended high pitched crying episodes starting that night and lasting for two weeks.  Within 3 days, he had developed eczema (with no dietary or environmental triggers), which spread over his whole body.  He went from a happy, easy-going baby to a very fussy unhappy baby overnight.  He continues to show signs of asthma and allergies.
Gastric Hemorrhage. Asphyxiation of hemorrhage ultimately resulting in death.
Vaccine to patient but it turned out that they were not stored within CDC guidelines; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine to patient but it turned out that they were not stored within CDC guidelines) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine to patient but it turned out that they were not stored within CDC guidelines). At the time of the report, PRODUCT STORAGE ERROR (Vaccine to patient but it turned out that they were not stored within CDC guidelines) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   It was reported that, one dose was Moderna vaccine were gave to patient but it turned out that they were not stored within the CDC guidelines reporter stated need to double check.
I experienced throbbing pain and burning of the left upper arm starting about 9 hours after getting the injection.  Over the next few hours I developed nausea, muscle aches, a large (approximately 6 inches by 6 inches) raised hard lump on my left upper arm, and a large hot red area over most of my upper left arm. The pain, burning, aches, nausea, and lump continue at the time of this report (approximately 48 hours after getting the vaccine).
I had a dentist appointment in the afternoon. They require a negative COVID test. I did not really have symptoms other than fatigue. When my home test was positive, I called the pharmacy and went and got the PCR test and got an appointment and that was also positive. By that evening, I had a very sore throat, I had a temp as high as 103, respiratory issues which led me to do a telehealth appointment. I was given an inhaler for the breathing issue. These symptoms lasted for about five days. I am still exhausted to this day and the fatigue has continued along with hair loss.
The pt experienced extreme lethargy and restlessness beginning on 3/15/00. The pt quit eating, walking and playing. All he did was cry and sleep. Mother called MD on 3/16 or 3/17 to report reaction.